These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
272 related items for PubMed ID: 393296
1. Prostaglandins as inhibitors of human platelet aggregation. Di Minno G, Silver MJ, de Gaetano G. Br J Haematol; 1979 Dec; 43(4):637-47. PubMed ID: 393296 [Abstract] [Full Text] [Related]
2. Combined effect of prostaglandins and an aortic proteoglycan on platelet aggregation and plasma clotting. Ts'ao C, Eisenstein R. Prostaglandins Med; 1979 Sep; 3(3):159-66. PubMed ID: 399532 [Abstract] [Full Text] [Related]
3. On the multiplicity of platelet prostaglandin receptors. I. Evaluation of competitive antagonism by aggregometry. Andersen NH, Eggerman TL, Harker LA, Wilson CH, De B. Prostaglandins; 1980 May; 19(5):711-35. PubMed ID: 6252573 [Abstract] [Full Text] [Related]
4. Platelet sensitivity to antiaggregatory prostaglandins (PGE1,D2,I2) in patients with peripheral vascular disease. Fitscha P, Kaliman J, Sinzinger H. Am J Hematol; 1985 May; 19(1):13-9. PubMed ID: 3885723 [Abstract] [Full Text] [Related]
8. Influences of prostaglandins on electrophoretic mobility and aggregation of rabbit platelets. Takano S, Itagaki S, Sakurai K, Suzuki T. Prostaglandins; 1980 Sep; 20(3):579-86. PubMed ID: 6999547 [Abstract] [Full Text] [Related]
9. 6-Keto-prostaglandin E1 inhibits the aggregation of human platelets. Wong PY, McGiff JC, Sun FF, Lee WH. Eur J Pharmacol; 1979 Dec 07; 60(2-3):245-8. PubMed ID: 393526 [Abstract] [Full Text] [Related]
10. The PGI2-analogue iloprost and the TXA2-receptor antagonist sulotroban synergistically inhibit TXA2-dependent platelet activation. Stürzebecher S, Witt W. Prostaglandins; 1988 Dec 07; 36(6):751-60. PubMed ID: 2469101 [Abstract] [Full Text] [Related]
11. Regulation of human platelet activation--analysis of cyclooxygenase and cyclic AMP-dependent pathways. Krishnamurthi S, Westwick J, Kakkar VV. Biochem Pharmacol; 1984 Oct 01; 33(19):3025-35. PubMed ID: 6091666 [Abstract] [Full Text] [Related]
13. Heparin counteracts the antiaggregating effect of prostacyclin by potentiating platelet aggregation. Bertelé V, Roncaglioni MC, Donati MB, de Gaetano G. Thromb Haemost; 1983 Apr 28; 49(2):81-3. PubMed ID: 6346573 [Abstract] [Full Text] [Related]
14. Comparison of inhibitory actions of prostacyclin and a new prostacyclin analogue on the aggregation of human platelet in whole blood. Saniabadi AR, Belch JJ, Lowe GD, Barbenel JC, Forbes CD. Haemostasis; 1987 Apr 28; 17(3):147-53. PubMed ID: 2440771 [Abstract] [Full Text] [Related]
16. The use of prostacyclin in the separation from plasma and washing of human platelets. Vargas JR, Radomski M, Moncada S. Prostaglandins; 1982 Jun 28; 23(6):929-45. PubMed ID: 6812168 [Abstract] [Full Text] [Related]
18. Platelet aggregation in human whole blood after chronic administration of aspirin. de la Cruz JP, Camara S, Bellido I, Carrasco T, Sanchez de la Cuesta F. Thromb Res; 1987 Apr 01; 46(1):133-40. PubMed ID: 3109069 [Abstract] [Full Text] [Related]
19. Prostacyclin-synthesis stimulating plasma factor and platelet sensitivity in preeclampsia. Dadak C, Kefalides A, Sinzinger H. Biol Res Pregnancy Perinatol; 1985 Apr 01; 6(2):65-9. PubMed ID: 3893552 [Abstract] [Full Text] [Related]